ATEA PHARMACEUTICALS

Serial Number 90513149
734

Registration Progress

Application Filed
Feb 5, 2021
Under Examination
Dec 14, 2021
Approved for Publication
Oct 19, 2021
Published for Opposition
Oct 19, 2021
Registered

Trademark Image

ATEA PHARMACEUTICALS

Basic Information

Serial Number
90513149
Filing Date
February 5, 2021
Published for Opposition
October 19, 2021
Drawing Code
4

Status Summary

Current Status
Active
Status Code
734
Status Date
Jun 14, 2024
Application
Pending
Classes
005

Rights Holder

Atea Pharmaceuticals, Inc.

03
Address
225 Franklin Street, Suite 2100
Boston, MA 02110

Ownership History

Atea Pharmaceuticals, Inc.

Original Applicant
03
Boston, MA

Atea Pharmaceuticals, Inc.

Owner at Publication
03
Boston, MA

Legal Representation

Attorney
Theodore H. Davis Jr.

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

35 events
Date Code Type Description Documents
Jun 14, 2024 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jun 14, 2024 EXT5 S SOU EXTENSION 5 FILED Loading...
Jun 14, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 14, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 15, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 13, 2023 EXT4 S SOU EXTENSION 4 FILED Loading...
Dec 13, 2023 EX4G S SOU EXTENSION 4 GRANTED Loading...
Dec 13, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 6, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 2, 2023 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jun 2, 2023 EXT3 S SOU EXTENSION 3 FILED Loading...
Jun 2, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 15, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 13, 2022 EX2G S SOU EXTENSION 2 GRANTED Loading...
Dec 13, 2022 EXT2 S SOU EXTENSION 2 FILED Loading...
Dec 13, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 8, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Sep 8, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Sep 8, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Mar 5, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 3, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
Mar 3, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Mar 3, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 14, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 19, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 19, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 29, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 14, 2021 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Sep 14, 2021 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Sep 14, 2021 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Sep 14, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 14, 2021 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Aug 30, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
May 10, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 9, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, anti-virals

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMACEUTICALS"